# Cross-session log entry — guideline-risk-intelligence, Wave 1

PROJECT_ID: `pitavastatin-ezetimibe-evidence` · RUN_ID: `2026-08-31-v1`
Date: 2026-08-31

## Outbound: CROSS_SESSION_TEST → Research Director

```text
[PROJECT] pitavastatin-ezetimibe-evidence
[RUN] 2026-08-31-v1
[FROM] guideline-risk-intelligence
[TO] Research Director
[TYPE] CROSS_SESSION_TEST
[FINDING] guideline-risk-intelligence peer online and reachable. Read CLAUDE.md, docs/
CROSS-SESSION-RESEARCH-RUNBOOK.md, pitavastatin topic.md, and all governance files (00-05) for RUN
2026-08-31-v1. Confirmed current Gate = READY_FOR_NEXT_WAVE, Wave 1 assigned.
[ACTION] Proceeding with Wave 1 Source/Evidence Verification for guideline-risk domain.
[STATUS] READY_FOR_NEXT_WAVE
```

## Inbound: TASK_ASSIGNMENT ← Research Director

```text
[TYPE] TASK_ASSIGNMENT
[FINDING] CROSS_SESSION_TEST received and acknowledged. Scope approved as-is (target-based therapy
framing, ESC 2025 Focused Update, 2026 ACC/AHA goals/PREVENT/CAC/Lp(a)/ApoB, Taiwan STS 2026, Taiwan
Lp(a) 2026, citations #1,2,17,18,24,27,28,29,30,31,32, Tonvasca_2026.md remainder).
[ACTION] Proceed; tag Evidence Hierarchy on every claim; preserve Numeric Integrity; report
verification findings to Director (do not edit 02_SOURCE-INVENTORY.md / 05_STATUS.md /
03_DECISION-LOG.md directly).
[STATUS] READY_FOR_NEXT_WAVE
```

## Outbound: STATUS_REPORT → Research Director (Wave 1 complete)

See message sent via SendMessage immediately after this log entry, schema per `CLAUDE.md` §6.
Summary: 11/11 assigned citations verified (1 DOI discrepancy flagged), 2 new citations found and
resolved from the previously-unread `Tonvasca_2026.md` remainder, all 3 outstanding Search Protocol
guideline targets (T-005 Taiwan STS 2026, T-006 Taiwan Lp(a) 2026, T-007 ESC 2025 Focused Update)
located and citation-verified. One compliance concern raised (research_hub's download tool touching
Sci-Hub internally) and MCP connectivity changes since Wave 0 noted. Full-text extraction deferred to
Wave 2.

Output paths: `10_DATA/guideline-risk/citation-verification-table.md`,
`20_EVIDENCE/guideline-risk/evidence-map.md`, `20_EVIDENCE/guideline-risk/unresolved-questions.md`,
`30_METHODS/guideline-risk/search-log.md`, `30_METHODS/guideline-risk/fulltext-manifest.md`.

## Follow-up note (2026-08-31): fulltext-manifest.md audited for Huang 2022 (#35) entry

Ran a narrow verification pass on the Huang PH et al. 2022 Taiwan primary-prevention guideline
full-text artifacts referenced in `wave2-item6-extraction.md` §D (commit `d5e5131`), which had never
been given its own manifest entry. Confirmed independently, this session: DOI/PMID resolve and match
via Europe PMC REST API; SHA-256 of both the PDF and parsed markdown recomputed and match the values
recorded at extraction time; the CC BY 4.0 license statement is present verbatim, twice, in the
parsed text itself (not merely asserted); both files remain gitignored and untracked (`git
check-ignore -v`, `git ls-files`); LlamaParse output is clean and well-formed (740 lines, no
corruption). Added a full structured entry to `30_METHODS/guideline-risk/fulltext-manifest.md`
recording all of the above. No shared/other-role files touched.
